Correlation of triple repeats on the FMR1 (fragile X) gene to ovarian reserve: A new infertility test?

References

• Wittenberger MD, Hagerman RJ, Sherman SL, Mc Conkie-Rosell A, Welt CK, Rebar RW, Corrigan EC, Simpson JL, Nelson LM. The FMR1 premutation and reproduction. Fertil Steril. 2007; 87: 456–65
   PubMed Web of Science ®Google Scholar
• Murray A, Ennis S, MacSwiney F, Webb J, Morton NE. Reproductive and menstrual history of females with fragile X expansions. Europ J Hum Genet 2000; 8: 247–52
   PubMed Web of Science ®Google Scholar
• Hundscheid RDL, Braat DDM, Kiemeney LALM, Smits APT, Thomas CMG. Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives. Hum Reprod 2001; 16: 457–62
   PubMed Web of Science ®Google Scholar
• Welt CK, Smith PC, Taylor AE. Evidence of early ovarian aging in fragile X premutation carriers. J Clin Endo Metab 2004; 89: 4569–74
   PubMed Web of Science ®Google Scholar
• Allen EG, Sullivan AK, Marcus M, Small C, Dominguez C, Epstein MP, Charen K, He W, Taylor KC, Sherman SL. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod. 2007; 22: 2142–52
   PubMed Web of Science ®Google Scholar
• Bodega B, Bione S, Dalpra L, Toniolo D, Ornaghi F, Vegetti W, Ginelli E, Marozzi A. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod. 2006; 21: 952–7
   PubMed Web of Science ®Google Scholar
• Brethererick KL, Fluker MR, Robinson WP. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet 2005; 117: 376–82
   PubMed Web of Science ®Google Scholar
• Bächner D, Steinbach P, Wohrle D, Just W, Vogel W, Hameister H, Manca A, Poustka A. Enhanced Fmr-1 expression in testis. Nat Genet. 1993; 4: 115–6
   PubMed Web of Science ®Google Scholar
• Laggerbauer B, Ostareck D, Keidel E-M, Ostareck-Lederer A, Fischer U. Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum Mol Genet 2001; 10: 329–38
   PubMed Web of Science ®Google Scholar
• Gleicher N, Weghofer A, Barad DH. A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone. Fertil Steril 2009; 91: 1700–6
   PubMed Web of Science ®Google Scholar
• Gleicher N, Weghofer A, Barad DH. A pilot study of premature ovarian senescence: II. Different genotype and phenotype for genetic and autoimmune etiologies. Fertil Steril. 2009; 91: 1707–11
   PubMed Web of Science ®Google Scholar
• Bächner D, Manca A, Steinbach P, Wohrle D, Just W, Vogel W, Hamesiter H, Poustka A. Enhanced expression of the murine FMR1 gene during germ cell proliferation suggests a special function in both the male and female gonad. Hum Mol Genet. 1993; 2: 2043–50
   PubMed Web of Science ®Google Scholar
• Rife M, Nadal A, Milà M, Willemsen R. Immunohistochemical FMRP studies in a full mutated female fetus. Am J Med Genet 2004; 124A: 129–32
   PubMed Web of Science ®Google Scholar
• Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJ, Holden JJ, Fenwick RG, Jr, Warren ST, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 1991; 67: 1047–58
   PubMed Web of Science ®Google Scholar
• Nikolaou D, Templeton A. Early ovarian ageing: a hypothesis. Detection and clinical relevance. Hum Reprod. 2003; 18: 1137–9
   PubMed Web of Science ®Google Scholar
• Gleicher N. Ovarian aging: is there a “norm”?. Cont ObGyn. 2005; 50: 65–75
   Google Scholar
• Sullivan AK, Marcus M, Epstein MP, et al. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod. 2005; 20: 402–12
   PubMed Web of Science ®Google Scholar
• Barad DH, Weghofer A, Gleicher N. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function. Obstet Gynecol 2007; 109: 1404–10
   PubMed Web of Science ®Google Scholar
• Weghofer A, Barad D, Li J, Gleicher N. Aneuploidy rates in embryos from women with prematurely declining ovarian function: a pilot study. Fertil Steril 2007; 88: 90–4
   PubMed Web of Science ®Google Scholar
• Munne S, Alikani M, Tomkin G, Grifo J, Cohen J. Embryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities. Fertil Steril 1995; 64: 382–91
   PubMed Web of Science ®Google Scholar
• ACOG Committee Opinion. No 338: screening for fragile X syndrome. Obstet Gynecol. 2006;107:1483–5
   PubMedGoogle Scholar
• Sherman S, Pletcher BA, Driscoll DA. Fragile X syndrome: diagnostic and carrier testing. Genet Med 2005; 7: 584–7
   PubMed Web of Science ®Google Scholar
• Bodani, U, Mehta, K, Savjani, G. A rapid enzyme linked immunoabsorbent assay (ELISA) for measurement of antimullerian hormone (AMH) in serum. AACC Annual meeting, E-118. September 11–14, 2005, Orlando, Florida
   Google Scholar
• Weenen C, Laven JS, Von Bergh AR, Craufield M, Groome NP, Visser JA, Kramer P, fauser BC, Themmen AP. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004; 10: 77–83
   PubMed Web of Science ®Google Scholar
• Faddy MJ. Follicle dynamics during ovarian ageing. Mol Cell Endocrinol 2000; 163: 43–8
   PubMed Web of Science ®Google Scholar
• Fleming R. Recruitment prior to ovarian stimulation: ways of improving follicular recruitment. Reprod Med Online 2005; 10: 55–9
   PubMed Web of Science ®Google Scholar